X8C

1-[2,6-bis(chloranyl)phenyl]carbonyl-4-[[2,6-bis(chloranyl)phenyl]carbonylamino]-N-piperidin-4-yl-pyrazole-3-carboxamide

Created:	2023-07-25
Last modified:	2025-02-05

Find Related PDB Entry
1 entries where X8C is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	54
Chiral Atom Count	0
Bond Count	57
Aromatic Bond Count	17

2D diagram of X8C

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[2,6-bis(chloranyl)phenyl]carbonyl-4-[[2,6-bis(chloranyl)phenyl]carbonylamino]-N-piperidin-4-yl-pyrazole-3-carboxamide
Synonyms	4-(2,6-dichlorobenzamido)-1-(2,6-dichlorobenzoyl)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide
Systematic Name (OpenEye OEToolkits)	1-[2,6-bis(chloranyl)phenyl]carbonyl-4-[[2,6-bis(chloranyl)phenyl]carbonylamino]-~{N}-piperidin-4-yl-pyrazole-3-carboxamide
Formula	C₂₃ H₁₉ Cl₄ N₅ O₃
Molecular Weight	555.241
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Clc1cccc(Cl)c1C(=O)Nc2cn(nc2C(=O)NC3CCNCC3)C(=O)c4c(Cl)cccc4Cl
SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(c(c1)Cl)C(=O)Nc2cn(nc2C(=O)NC3CCNCC3)C(=O)c4c(cccc4Cl)Cl)Cl
Canonical SMILES	CACTVS	3.385	Clc1cccc(Cl)c1C(=O)Nc2cn(nc2C(=O)NC3CCNCC3)C(=O)c4c(Cl)cccc4Cl
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(c(c1)Cl)C(=O)Nc2cn(nc2C(=O)NC3CCNCC3)C(=O)c4c(cccc4Cl)Cl)Cl
InChI	InChI	1.06	InChI=1S/C23H19Cl4N5O3/c24-13-3-1-4-14(25)18(13)21(33)30-17-11-32(23(35)19-15(26)5-2-6-16(19)27)31-20(17)22(34)29-12-7-9-28-10-8-12/h1-6,11-12,28H,7-10H2,(H,29,34)(H,30,33)
InChIKey	InChI	1.06	NFMDNCVFXJZSGE-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	172652623

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.